Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Ranolazine on Gastrointestinal Motor Function and Pain in Patients With Diarrhea-predominant Irritable Bowel Syndrome (IBS-D)

NCT02239926 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT02239926
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02239926 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Ranolazine on Gastrointestinal Motor Function and Pain in Patients With Diarrhea-predominant Irritable Bowel Syndrome (IBS-D)
Lead sponsor
Mayo Clinic
Phase
Phase 2/3
Overall status
Terminated
Start date
September 30, 2014
Completion date
September 30, 2015
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diarrhea predominant irritable bowel syndrome